The Relation Therapeutics team (L-R): CSO Edith Hessel, COO Benjamin Swerner, SVP, growth and operations Rosie Rodriguez, CTO Lindsay Edwards and CEO David Roblin
March 13, 2024 07:00 AM EDT
Financing
Startups
AI

Ex­clu­sive: ‘Chat­G­PT for DNA’: Re­la­tion nabs $35M, with Nvidia back­ing, for os­teo­poro­sis work

Kyle LaHucik

Senior Reporter

The ven­ture arm of Nvidia, the su­per­com­put­ing gi­ant ris­ing up the world’s most valu­able com­pa­nies chart, is back­ing a com­pu­ta­tion­al drug dis­cov­ery …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

NewAms­ter­dam aces Phase 3 tri­al, but in­vestors are skep­ti­cal

Pfiz­er part­ners with two more Flag­ship biotechs on obe­si­ty, can­cer

Post-Hoc: RFK vs. Vivek, and the fu­ture of US drug pol­i­cy

FDA up­dates la­bel of 33-year-old can­cer drug with new dose and warn­ing

Car­olyn Bertozzi’s lat­est biotech de­buts with $30M seed round and a sug­ary spin on im­munother­a­py

sponsored

Are pro­grams with com­pound­ed GLP-1s safe for your pop­u­la­tion?

A service from the Financial Times